Myriad Genetics Inc (MYGN)

EBITDA Margin

-5.60%

TTM · Period ending:

MYGN logo

MYGN EBITDA Margin

Latest reported-5.60%
MYGN TTM EBITDA Margin (-81.82% → -5.60%)
High-resolution chart · PNG

MYGN ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Myriad Genetics Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-20.8314%
-21.9481%
-22.7905%
-23.1251%
-24.194%
-24.9662%
-26.1911%
-32.5196%
-37.3598%
-40.3742%
-45.9574%
-45.8515%
-42.2414%
-27.686%
-34.434%
-46.0317%
-65.7895%
-130.9278%
-131.4607%
-123.0769%
-81.8182%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.